is xigduo a glp-1 XR: Dosage & Side Effects Medication Options for Type 2
Description
New England Journal of Medicine, 389(10), 877888
OAC provides tools to: Sign petitions Contact elected representatives Support active federal and state legislation Share experiences that inform policy advocacy Learn more and take action at obesityaction.org/action-center Policy change takes time, but its the only path to permanently ending blanket exclusions for obesity treatment
doi: 10.1007/s00395-023-01018-w, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 63
However, the long-term implications of prolonged GLP-1 medication use remain a topic of ongoing research and debate, Thompson says
10.1016/j.numecd.2016.01.011 32
